VivoPower PLC is engaged in building, owning, and leasing powered land and data center infrastructure for AI compute applications... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CDEI | 93.77 | N/A | N/A |
| Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF (CDEI) | |||
| PWRL | 11.32 | N/A | N/A |
| Powerlaw Corp | |||
| DDX | 24.96 | -0.01 | -0.03% |
| Defined Duration 10 ETF (DDX) | |||
| DFIP | 39.85 | -0.07 | -0.18% |
| Dimensional Inflation-Protected Securities ETF (DFIP) | |||
| KSTR | 16.72 | -0.43 | -2.51% |
| KraneShares China Technology & Semiconductor STAR 50 Index ETF (KSTR) | |||
A.I.dvisor indicates that over the last year, VIVO has been loosely correlated with INSP. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVO jumps, then INSP could also see price increases.
| Ticker / NAME | Correlation To VIVO | 1D Price Change % | ||
|---|---|---|---|---|
| VIVO | 100% | -27.44% | ||
| INSP - VIVO | 41% Loosely correlated | -7.90% | ||
| ICLR - VIVO | 38% Loosely correlated | -0.67% | ||
| BRKR - VIVO | 37% Loosely correlated | +1.45% | ||
| GMED - VIVO | 36% Loosely correlated | +0.15% | ||
| TMO - VIVO | 35% Loosely correlated | +2.30% | ||
More | ||||
| Ticker / NAME | Correlation To VIVO | 1D Price Change % |
|---|---|---|
| VIVO | 100% | -27.44% |
| diagnostics theme (19 stocks) | 13% Poorly correlated | +0.61% |
| biotechnology theme (201 stocks) | 11% Poorly correlated | +1.29% |
| cancer theme (69 stocks) | 11% Poorly correlated | +0.31% |
| Computer Communications theme (167 stocks) | 10% Poorly correlated | +0.49% |
| drugs theme (212 stocks) | 9% Poorly correlated | +1.09% |
a manufacturer of diagnostic products
Industry ComputerCommunications
The Stochastic Oscillator for VIVO moved into oversold territory on November 03, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The RSI Indicator entered the oversold zone -- be on the watch for VIVO's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
Following a +15.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIVO advanced for three days, in 186 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
VIVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VIVO as a result. In 79 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for VIVO turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 42 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 50-day moving average for VIVO moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VIVO entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. VIVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.139) is normal, around the industry mean (16.526). P/E Ratio (-0.833) is within average values for comparable stocks, (57.809). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.287) among similar stocks. P/S Ratio (769.231) is also within normal values, averaging (103.889).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.